VeriMomoligopeptide-62 est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety assessment was identified for oligopeptide-62, and no peer-reviewed animal or human reproductive toxicity studies were found in the literature reviewed. As a short peptide ingredient with no evidence of systemic reproductive mechanism, default low-hazard rating is applied (sources searched: ECHA Annex VI, SCCS/CIR databases, PubMed, PubChem, CosIng, EWG).
Related ingredients
Frequently asked questions
- oligopeptide-62 est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety assessment was identified for oligopeptide-62, and no peer-reviewed animal or human reproductive toxicity studies were found in the literature reviewed. As a short peptide ingredient with no evidence of systemic reproductive mechanism, default low-hazard rating is applied (sources searched: ECHA Annex VI, SCCS/CIR databases, PubMed, PubChem, CosIng, EWG).
- oligopeptide-62 est-il sûr pendant l'allaitement ?
- There are no data indicating reproductive or lactation-specific toxicity, no regulatory or peer-reviewed reports of effects on breastfeeding or milk transfer for oligopeptide-62, and no harmonised classifications (ECHA Annex VI). By default and in absence of evidence, hazard and mechanism scores are 0; expected systemic exposure from typical topical cosmetic use is negligible. Sources searched: SCCS/CIR, PubMed, PubChem, CosIng, EWG.
- oligopeptide-62 est-il sûr pour la peau de bébé ?
- No infant-specific safety data were identified. Hazard/mechanism remain 0 due to lack of reproductive/toxicological evidence; exposure score is increased to 1 for baby skin because infants have a more permeable stratum corneum and higher surface-area-to-weight ratio, so measurable percutaneous absorption cannot be excluded for a low‑molecular‑weight peptide. No harmonised CLP or regulatory contraindication was found. Sources searched: PubMed, PubChem, CosIng, ECHA Annex VI, EWG.
- Comment VeriMom évalue-t-il oligopeptide-62 ?
- VeriMom évalue oligopeptide-62 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à oligopeptide-62 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à oligopeptide-62 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.